05:12 PM EDT, 08/15/2024 (MT Newswires) -- Carl L Gordon, Director, on August 13, 2024, sold 250,000 shares in Keros Therapeutics ( KROS ) for $11,002,500. Following the Form 4 filing with the SEC, Gordon has control over a total of 119,522 shares of the company, with 119,522 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1664710/000094787124000703/xslF345X03/ownership.xml